- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05946161
Testing an e-Health Intervention for Prostate Cancer Survivors' Mental and Sexual Health
A Digital Intervention Program to Promote Mental and Sexual Health of Prostate Cancer Survivors
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
This study was approved by the Ethical Board of São João Hospital, Porto. An online psychological intervention (e-Health app technology) specifically tailored to meet the needs of Portuguese men with prostate cancer was developed to promote participants' mental and sexual health. The intervention protocol was designed under Cognitive-Behavior Therapy (CBT) principles, featuring psychological and sexual health promotion strategies. The intervention program consists of 5 modules covering components of psychoeducation, sexual rehabilitation, mindfulness, cognitive restructuring, and relapse prevention. The modules will be delivered online (using text, videos, and graphics) along with therapeutic guidance and support provided by a certified Clinical Psychologist over six weeks.
Participants will be recruited at cancer units and will meet the inclusion criteria: prostate cancer survivors; 18 years old or older; ability to give informed consent; regular use of a smartphone and internet access; no other oncological diagnoses over the past five years, no severe neurological or psychological disorders. Participants will be randomly assigned to one of two conditions: 1) e-Health psychological intervention (N = 20); 2) waiting list group, N = 20). Participants will be clinically assessed before and after intervention on different psychosexual dimensions (e.g., mental health, quality of life, sexual dysfunction). By the end of the study, the waiting list group participants will be allowed to access the e-Health psychological intervention. The experimental group is expected to improve regarding mental and sexual well-being outcomes compared to the control group. Furthermore, the experimental group is expected to show the program's acceptability. This study aims to inform a future a randomized control trial that aims to further test the e-Health intervention's efficacy. Pre, post-test, and 3-month follow-up assessments will be performed.
Main outcomes: psychological distress, sexual distress, sexual satisfaction, relational satisfaction, sexual dysfunctional beliefs, and quality of life. All scales are validated and adapted to the Portuguese population. Furthermore, a semi-structured interview will be conducted with experimental group participants by the end of the study to collect user feedback.
Participants' data will be stored in an encrypted file, saved on a computer, and only accessible to the main researchers of this study. Confidentiality will be guaranteed by attributing an individual code to each participant. This code will be used to log into the digital intervention and complete psychometric scales. Interviews will be recorded and transcribed. Transcriptions will be marked with the same code to ensure the association of the collected data.
Statistical procedures will be performed using IBM SPSS and include i) descriptive analyses; ii) MANOVA to measure differences among groups and to compare assessment moments; iii) thematic analysis to understand the user's experience (post-intervention interview)
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Ana Luisa Quinta Gomes, PhD
- Phone Number: +351965816335
- Email: anagomes@fpce.up.pt
Study Locations
-
-
-
Porto, Portugal, 4200-135
- Recruiting
- Faculty of Psychology and Educational Sciences
-
Contact:
- Ana Luisa Quinta Gomes, PhD
- Phone Number: +351965816335
- Email: anagomes@fpce.up.pt
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Prostate cancer survivors,
- 18 years old or older,
- Ability to give informed consent,
- Regular use of a smartphone and internet access.
Exclusion Criteria:
- Other diagnosed oncological diseases over the past five years,
- Severe neurological impairment or other severe psychological/psychiatric diseases (depression, generalized anxiety disorder, psychosis-related disorders),
- Other uncontrolled/unstable diseases,
- Severe hearing and/or visual impairment,
- Under psychotherapy or treatment for sexual problems,
- Participating concurrently in other clinical trials.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: testing the digital intervention
Prostate cancer survivors (n=20) randomly assigned to this arm will complete a digital psychosexual intervention and will be accompanied weekly by a certified clinical psychologist to monitor progress (synchronous or asynchronous).
Pre and Post testing involve questionnaires collecting data on psychosexual variables.
At post-testing a 30-minute interview will be conducted to collect information on the usability
|
An online psychological intervention (e-Health app technology) specifically tailored to meet the needs of Portuguese men with prostate cancer was developed to promote participants' mental and sexual health.
The intervention protocol was designed under the principles of Cognitive Behavior Therapy (CBT), featuring psychological and sexual health promotion strategies.
The intervention program consists of 5 modules covering components of psychoeducation, sexual rehabilitation, mindfulness, cognitive restructuring and relapse prevention.
The modules will be delivered online (using text, videos, and graphics) along with therapeutic guidance and support provided by a certified Clinical Psychologist, over a 6-week period.
|
No Intervention: waiting list
Prostate cancer survivors (n=20) randomly assigned to this arm will not be accompanied or get access to the intervention during the six week period in which the experimental group is completing the intervention.
Pre and Post testing involved questionnaires collecting data on psychosexual variables.
After post testing the control arm will gain access to the intervention as compensation for their participation
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Brief Symptom Inventory
Time Frame: Change from baseline psychological distress at final program (6 weeks)
|
Questionnaire to assess psychological distress
|
Change from baseline psychological distress at final program (6 weeks)
|
Sexual Distress Scale
Time Frame: Change from baseline sexual distress at final program (6 weeks)
|
Questionnaire to assess sexual distress
|
Change from baseline sexual distress at final program (6 weeks)
|
WHOQoL-BREF
Time Frame: Change from baseline quality of life at final program (6 weeks)
|
Questionnaire to assess quality of life
|
Change from baseline quality of life at final program (6 weeks)
|
Global Measure of Sexual Satisfaction
Time Frame: Change from baseline sexual satisfaction at final program (6 weeks)
|
Questionnaire to assess sexual satisfaction
|
Change from baseline sexual satisfaction at final program (6 weeks)
|
Global Measure of Relationship Satisfaction
Time Frame: Change from baseline relationship satisfaction at final program (6 weeks)
|
Questionnaire to assess relationship satisfaction
|
Change from baseline relationship satisfaction at final program (6 weeks)
|
System Usability Scale
Time Frame: Post assessment - through study completation, (6 weeks)
|
Questionnaire to assess acceptability and usability
|
Post assessment - through study completation, (6 weeks)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
International Index of Erectile Function
Time Frame: Change from baseline sexual function at final program (6 weeks)
|
Questionnaire to assess sexual function
|
Change from baseline sexual function at final program (6 weeks)
|
Dysfunctional Sexual Beliefs Questionnaire
Time Frame: Change from baseline dysfunctional sexual beliefs at final program (6 weeks)
|
Questionnaire to assess dysfunctional sexual beliefs
|
Change from baseline dysfunctional sexual beliefs at final program (6 weeks)
|
Collaborators and Investigators
Sponsor
Collaborators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- NORTE-01-0145-FEDER-000057
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Prostate Cancer
-
Roswell Park Cancer InstituteRecruitingObesity | Overweight | Cancer Survivor | Prostate Adenocarcinoma | Stage I Prostate Cancer | Stage II Prostate Cancer | Stage III Prostate Cancer | Stage IV Prostate Cancer | Stage IIA Prostate Cancer | Stage IIB Prostate Cancer | Stage IVA Prostate Cancer | Stage IVB Prostate Cancer | Stage A Prostate Cancer | Stage... and other conditionsUnited States
-
Sidney Kimmel Cancer Center at Thomas Jefferson...Regeneron Pharmaceuticals; Prostate Cancer FoundationWithdrawnStage III Prostate Cancer | Stage IV Prostate Cancer | Stage IVA Prostate Cancer | Stage IVB Prostate Cancer | Stage IIIA Prostate Cancer | Stage IIIB Prostate Cancer | Stage IIIC Prostate Cancer
-
University of Southern CaliforniaNational Cancer Institute (NCI); SanofiTerminatedDiarrhea | Recurrent Prostate Cancer | Hormone-resistant Prostate Cancer | Stage I Prostate Cancer | Stage III Prostate Cancer | Stage IV Prostate Cancer | Stage IIA Prostate Cancer | Stage IIB Prostate CancerUnited States
-
Jonsson Comprehensive Cancer CenterProgenics Pharmaceuticals, Inc.TerminatedRandomized Trial of PSMA PET Scan Before Definitive Radiation Therapy for Prostate Cancer (PSMA-dRT)Stage II Prostate Cancer AJCC v8 | Stage IIIA Prostate Cancer AJCC v8 | Stage IIIB Prostate Cancer AJCC v8 | Stage IIC Prostate Cancer AJCC v8 | Stage III Prostate Cancer AJCC v8 | Stage IIIC Prostate Cancer AJCC v8 | Stage IIA Prostate Cancer AJCC v8 | Stage IIB Prostate Cancer AJCC v8 | Stage I Prostate...United States
-
Jonsson Comprehensive Cancer CenterNational Cancer Institute (NCI)CompletedRecurrent Prostate Cancer | Stage I Prostate Cancer | Stage III Prostate Cancer | Adenocarcinoma of the Prostate | Stage IV Prostate Cancer | Stage IIA Prostate Cancer | Stage IIB Prostate CancerUnited States
-
Ryan Kohlbrenner, MDRadiological Society of North AmericaCompletedProstate Adenocarcinoma | Stage IV Prostate Cancer AJCC v8 | Prostate Carcinoma | Stage IIIA Prostate Cancer AJCC v8 | Stage IIIB Prostate Cancer AJCC v8 | Stage IIC Prostate Cancer AJCC v8 | Stage III Prostate Cancer AJCC v8 | Stage IIIC Prostate Cancer AJCC v8 | Stage IVA Prostate Cancer AJCC v8 | Stage...United States
-
Ohio State University Comprehensive Cancer CenterRiverside Methodist HospitalCompletedStage I Prostate Cancer | Stage III Prostate Cancer | Stage IV Prostate Cancer | Stage IIA Prostate Cancer | Stage IIB Prostate CancerUnited States
-
University of California, IrvineCompletedRecurrent Prostate Cancer | Stage I Prostate Cancer | Stage III Prostate Cancer | Adenocarcinoma of the Prostate | Stage IIA Prostate Cancer | Stage IIB Prostate CancerUnited States
-
Mayo ClinicNational Cancer Institute (NCI)WithdrawnStage I Prostate Cancer AJCC v8 | Stage II Prostate Cancer AJCC v8 | Stage IIIA Prostate Cancer AJCC v8 | Stage IIIB Prostate Cancer AJCC v8 | Stage IIC Prostate Cancer AJCC v8 | Stage III Prostate Cancer AJCC v8 | Stage IIIC Prostate Cancer AJCC v8 | Stage IIA Prostate Cancer AJCC v8 | Stage IIB Prostate...United States
-
Barbara Ann Karmanos Cancer InstituteGenentech, Inc.CompletedRecurrent Prostate Cancer | Stage I Prostate Cancer | Stage III Prostate Cancer | Adenocarcinoma of the Prostate | Stage IIA Prostate Cancer | Stage IIB Prostate CancerUnited States
Clinical Trials on e-Health intervention to promote mental and sexual health of prostate cancer survivors
-
Singapore Institute for Clinical SciencesNational University Polyclinics, Singapore; National University of SingaporeCompletedHealthy | Diabetes, Gestational | Gestational Diabetes Mellitus in PregnancySingapore
-
University of CalgaryMovember FoundationCompleted
-
University of LouisvilleWithdrawnDiabetes Mellitus, Type 1United States
-
Fundació Sant Joan de DéuFondazione I.R.C.C.S. Istituto Neurologico Carlo Besta; University of York; Universidad... and other collaboratorsNot yet recruitingDepression | Stress | Insomnia | Anxiety
-
University of California, San FranciscoPatient-Centered Outcomes Research InstituteCompletedUnsafe Sex | Unprotected SexUnited States
-
Case Comprehensive Cancer CenterCompletedRecurrent Prostate Cancer | Stage I Prostate Cancer | Adenocarcinoma of the Prostate | Stage IIA Prostate Cancer | Stage IIB Prostate CancerUnited States
-
McGill UniversityGlobal Affairs Canada; World Vision CanadaNot yet recruitingStunting | Diet; Deficiency | Empowerment | Acceptability of Health Care | Gender EqualityBangladesh, Kenya, Tanzania
-
University of Rhode IslandEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsCompletedPregnancy | Sexually Transmitted InfectionsUnited States
-
University of Medicine and Dentistry of New JerseyCenters for Medicare and Medicaid ServicesCompleted
-
St. Jude Children's Research HospitalNational Cancer Institute (NCI)RecruitingCancer | SurvivorshipUnited States